SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Eva-Maria Thurner, Sabine Krenn-Pilko, Uwe Langsenlehner, Tatjana Stojakovic, Martin Pichler, Armin Gerger, Karin S. Kapp, Tanja Langsenlehner, The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy, European Journal of Cancer, 2015, 51, 5, 610

    CrossRef

  2. 2
    Brieze R. Keeley, Farhad Islami, Akram Pourshams, Hossein Poustchi, Jamie S. Pak, Paul Brennan, Hooman Khademi, Eric M. Genden, Christian C. Abnet, Sanford M. Dawsey, Paolo Boffetta, Reza Malekzadeh, Andrew G. Sikora, Prediagnostic serum levels of inflammatory biomarkers are correlated with future development of lung and esophageal cancer, Cancer Science, 2014, 105, 9
  3. 3
    Bahadir Ceylan, Bilgül Mete, Muzaffer Fincanci, Turan Aslan, Yasemin Akkoyunlu, Nail Ozguneş, Onur Colak, Alper Gunduz, Ebubekir Senates, Resat Ozaras, Ayşe İnci, Fehmi Tabak, A new model using platelet indices to predict liver fibrosis in patients with chronic hepatitis B infection, Wiener klinische Wochenschrift, 2013, 125, 15-16, 453

    CrossRef

  4. 4
    Bahadir Ceylan, Muzaffer Fincanci, Cem Yardimci, Gülhan Eren, Ümit Tözalgan, Cüneyt Müderrisoğlu, Esra Paşaoğlu, Can mean platelet volume determine the severity of liver fibrosis or inflammation in patients with chronic hepatitis B?, European Journal of Gastroenterology & Hepatology, 2013, 25, 5, 606

    CrossRef

  5. 5
    William A. Hall, Dana C. Nickleach, Viraj A. Master, Roshan S. Prabhu, Peter J. Rossi, Karen Godette, Sherri Cooper, Ashesh B. Jani, The association between C-reactive protein (CRP) level and biochemical failure-free survival in patients after radiation therapy for nonmetastatic adenocarcinoma of the prostate, Cancer, 2013, 119, 18
  6. 6
    Renee C. Prins, Brooks L. Rademacher, Solange Mongoue-Tchokote, Joshi J. Alumkal, Julie N. Graff, Kristine M. Eilers, Tomasz M. Beer, C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): Confirmatory results, Urologic Oncology: Seminars and Original Investigations, 2012, 30, 1, 33

    CrossRef

  7. 7
    Hervé Lerat, Martin Higgs, Jean-Michel Pawlotsky, Animal models in the study of hepatitis C virus-associated liver pathologies, Expert Review of Gastroenterology & Hepatology, 2011, 5, 3, 341

    CrossRef

  8. 8
    Vinod Rustgi, Damaris Carriero, Michelle Bachtold, Gillian Zeldin, Update on Chronic Hepatitis B, The Journal for Nurse Practitioners, 2010, 6, 8, 631

    CrossRef

  9. 9
    Andrew R. Post, James H. Harrison, Temporal Data Mining, Clinics in Laboratory Medicine, 2008, 28, 1, 83

    CrossRef

  10. 10
    The Biology of Human Longevity, 2007,

    CrossRef

  11. 11
    Shamim Akhter, Huifeng Liu, Ramesh Prabhu, Cynthia DeLucca, Frank Bastian, Robert F Garry, Myron Schwartz, Swan N Thung, Srikanta Dash, Epstein–Barr virus and human hepatocellular carcinoma, Cancer Letters, 2003, 192, 1, 49

    CrossRef

  12. 12
    M.A. Barajas Gutiérrez, M. Espejo Romero, J.M. Baza Vilariño, Hepatitis viral aguda, FMC - Formación Médica Continuada en Atención Primaria, 2002, 9, 3, 159

    CrossRef

  13. 13
    Angus G. Dalgleish, Ken J. O'Byrne, 2002,

    CrossRef

  14. 14
    Kyoji Ogoshi, Kaichi Isono, HETEROZYGOTE ADVANTAGE AT MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) MOLECULES AND CANCER RISK, Annals of Cancer Research and Therapy, 2001, 9, 1-2, 73

    CrossRef

  15. 15
    Elizabeth A. Pomfret, James J. Pomposelli, Roger L. Jenkins, Live donor liver transplantation, Journal of Hepatology, 2001, 34, 4, 613

    CrossRef

  16. 16
    Andrea Rambaldi, Christian Gluud, Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis, The Cochrane Library,
  17. 17
    A Rambaldi, C Gluud, Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis, The Cochrane Library,